-
4721
Mesothelioma of the testis and nephrotic syndrome: a case report
Published 2009-06-01“…Solid tumors are preferentially associated with membranous nephropathy, whereas Hodgkin's lymphomas are associated with minimal change disease.…”
Get full text
Article -
4722
Mycosis fungoides and Sézary syndrome
Published 2021-06-01“…Mycosis fungoides (MF) and Sézary syndrome (SS) are two subgroups of cutaneous T-cell lymphomas (CTCL), which belong to the extranodal non-Hodgkin lymphomas. These are rare diseases whose etiology is still not fully understood. …”
Get full text
Article -
4723
Lower expression of mRNA for interferon-gamma in T helper cells of children with newly diagnosed lymphomas
Published 2011-08-01“…The aim of our study was to assess mRNA for pro- and anti-inflammatory cytokines in T-cells in 20 children with Hodgkin- and non-Hodgkin lymphomas. CD4<sup>+</sup> and CD8<sup>+</sup> cells were isolated from whole peripheral blood and four different cytokine mRNA levels (IFN-&#947;, IL-10, IL-4, TGF-&#946;) were determined by real-time PCR technique. …”
Get full text
Article -
4724
CAR T-Based Therapies in Lymphoma: A Review of Current Practice and Perspectives
Published 2022-08-01“…While more than half of non-Hodgkin lymphomas (NHL) can be cured with modern frontline chemoimmunotherapy regimens, outcomes of relapsed and/or refractory (r/r) disease in subsequent lines remain poor, particularly if considered ineligible for hematopoietic stem cell transplantation. …”
Get full text
Article -
4725
Primary Duodenal Mucosa-associated Lymphoid Tissue Lymphoma Treated with Radiation Therapy Alone
Published 2023-03-01“…Primary mucosa-associated with a lymphoid tissue (MALT) lymphoma is a rare distinct subtype of non-Hodgkin’s lymphoma that occurs in approximately 8% of all non-Hodgkin lymphomas. Primary gastrointestinal MALT lymphoma usually occurs in the stomach, but duodenal involvement is extremely rare. …”
Get full text
Article -
4726
Association of microRNA Polymorphisms with Toxicities Induced by Methotrexate in Children with Acute Lymphoblastic Leukemia
Published 2023-11-01“…Methotrexate (MTX), a structurally related substance to folic acid, is an important chemotherapeutic agent used for decades in the treatment of pediatric acute lymphoblastic leukemia (ALL) and other types of cancer as non-Hodgkin lymphomas and osteosarcomas. Despite the successful outcomes observed, the primary drawback is the variability in the pharmacokinetics and pharmacodynamics between patients. …”
Get full text
Article -
4727
Extranodal diffuse large B-cell lymphomas: A retrospective case series and review of the literature
Published 2018-04-01“…Non-Hodgkin lymphomas commonly show extranodal involvement (25-30%) but primary diffuse large B-cell lymphomas(DLBCL) with extranodal localization represent clinically and molecularly distinct entities. …”
Get full text
Article -
4728
Clinical experiences with venetoclax and other pro-apoptotic agents in lymphoid malignancies: lessons from monotherapy and chemotherapy combination
Published 2022-06-01“…Venetoclax is active in other lymphoid malignancies including several B cell non-Hodgkin lymphomas, acute lymphoblastic leukemia and multiple myeloma, with the highest intrinsic sensitivity observed in mantle cell lymphoma and Waldenstrom macroglobulinemia. …”
Get full text
Article -
4729
Hepatosplenic T Cell Lymphoma: Diagnostic Conundrum
Published 2022-01-01“…Hepatosplenic T cell lymphoma (HSTCL) is a very rare and aggressive peripheral T cell lymphoma that comprises less than 1% of Non-Hodgkin lymphomas (NHL). It is derived from cytotoxic T-cells, usually of γδ T cell receptor type, and is characterized by primary extranodal disease with typical sinusoidal infiltration of the liver, spleen, and bone marrow by medium-sized lymphoid cells. …”
Get full text
Article -
4730
Sciatic nerve neurolymphomatosis as the initial presentation of primary diffuse large B-cell lymphoma: a rare cause of leg weakness
Published 2021-07-01“…NL often occurs in malignant B-cell non-Hodgkin lymphomas. Notwithstanding its aggressiveness or intractability, NL should be discriminated from other neurologic complications of lymphoma. …”
Get full text
Article -
4731
Inhibition of the PI3K/Akt/mTOR Signaling Pathway in Diffuse Large B-Cell Lymphoma: Current Knowledge and Clinical Significance
Published 2014-09-01“…Diffuse large B-cell lymphoma (DLBCL) is one of the most common non-Hodgkin lymphomas in adults. The disease is very heterogeneous in its presentation, that is DLBCL patients may differ from each other not only in regard to histology of tissue infiltration, clinical course or response to treatment, but also in respect to diversity in gene expression profiling. …”
Get full text
Article -
4732
Early stage primary gastric diffuse large B-cell lymphoma in a young HIV-positive patient
Published 2014-06-01“…About 25 to 40% of HIV-positive patients will present some kind of malignancy in the course of the disease; among them 10% are non-Hodgkin lymphomas (NHL) and 20% of these are represented by the diffuse large B-cell lymphoma. …”
Get full text
Article -
4733
Role of pharmacogenetic factors in the development of side effects of methotrexate in the treatment of malignant tumors: A review
Published 2021-12-01“…Methotrexate (MTX) is one of the main chemotherapeutic agents that has determined the high effectiveness of protocols for the treatment of acute lymphoblastic leukemia and non-Hodgkin lymphomas. The reverse side of the high anti-tumor activity of MTX is the adverse reactions, which require accompanying preventive therapy. …”
Get full text
Article -
4734
Clinical Management of Patients with Gastric MALT Lymphoma: A Gastroenterologist’s Point of View
Published 2023-07-01“…Gastric mucosa-associated lymphoid tissue (MALT) lymphomas (GML) are non-Hodgkin lymphomas arising from the marginal zone of the lymphoid tissue of the stomach. …”
Get full text
Article -
4735
Rituximab Plus Chemotherapy Provides No Clinical Benefit in a Peripheral T-Cell Lymphoma not Otherwise Specified with Aberrant Expression of CD20 and CD79a: A Case Report and Revie...
Published 2020-05-01“…This phenotypic aberrancy may lead to misdiagnosis as B-cell non-Hodgkin lymphomas and eventual inappropriate patient management, whereas in an accurately diagnosed PTCL, the presence of CD20 may appear as an appealing therapeutic target. …”
Get full text
Article -
4736
Review of Glyphosate-Based Herbicide and Aminomethylphosphonic Acid (AMPA): Environmental and Health Impacts
Published 2022-09-01“…The chemical glyphosate has been linked to various health issues in humans and other living organisms, including endocrine disruption, reproductive issues, tumours, non-Hodgkin lymphomas, and liver, heart, and blood problems. …”
Get full text
Article -
4737
The Danish National Lymphoma Registry: Coverage and Data Quality.
Published 2016-01-01“…In addition, four subtypes of lymphomas were validated: CNS lymphomas, diffuse large B-cell lymphomas, peripheral T-cell lymphomas, and Hodgkin lymphomas. A total of 1,706 patients from the period 2000-2012 were included. …”
Get full text
Article -
4738
Clinical-epidemiological characterization of lymphomas on pediatric ages in Pinar del Rio, 2010-2016
Published 2017-06-01“…Results: a similar behavior regarding the number of non-Hodgkin's lymphomas diagnosed per years was observed; during 2015 no diagnoses were conducted. …”
Get full text
Article -
4739
Genes associated with diagnosis and prognosis of Burkitt lymphoma
Published 2022-12-01“…Abstract Burkitt lymphoma (BL) is one of the most aggressive forms of non‐Hodgkin's lymphomas that affect children and young adults. …”
Get full text
Article -
4740
Rare Causes of Isolated and Progressive Splenic Lesions: Challenges in Differential Diagnosis, Evaluation, and Treatment of Primary Splenic Lymphomas
Published 2020-06-01“…The spleen is among the most common extranodal sites for Hodgkin and non-Hodgkin lymphomas (NHLs); however, among lymphomas arising from the spleen, primary splenic lymphomas (PSLs) are rare. …”
Get full text
Article